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Nine years ago I collaborated with Dr. Esmond R. Long and the
late Dr. Lydia M. DeWitt in preparing a critical compilation of the
results obtained up to that time by chemical studies of tuberculosis,
published as The Chemistry of Tuberculosis. Dr. Long and I are
now revising this book, which gives us an opportunity to estimate
just what progress has been made in these nine years, and in what
direction. One section of that book dealt with the Chemotherapy
of Tuberculosis, a topic that had been attacked in our laboratory, at
first by myself, later by Drs. H. J. Corper and DeWitt, and there-
fore a subject in which we had a keen interest and considerable first-
hand experience. At that time systematic research on the chemo-
therapy of tuberculosis was being carried on as a definite program of
research in two places in this country, namely, in the Phipps Insti-
tute in Philadelphia under the late Paul Lewis, and in the Otho S. A.
Sprague Memorial Institute under my own direction. Elsewhere
whatever research was beingdone in this field was of a more sporadic
or opportunistic character. Feldt in Germany was studying the
possible chemotherapeutic value of gold salts, a subject he has con-
tinued to follow. With copper compounds a few experimental
observations were being made, inspired by enthusiastic but unjusti-
fied propaganda by the Grafin von Linden, who had revived a
waning interest in this ancient treatment of tuberculosis. Here and
there in Europe were appearing reports of scanty experimental and
uncontrolled clinical studies of variousspecial preparations,especially
of silica, calcium, and guaiacol, each bearing some trade name and
accredited with marvelous potencies which were not explained by
the known properties of the components. Most of these reports
were reminiscent of the line-"Puffs like a peddlar praising a pill".
The reason for the scantiness of systematic study of the chemo-
therapy of tuberculosis is apparent to anyone who has engaged in it.
Compared with almost any other infectious disease, the study of the
chemotherapy of tuberculosis is by all odds the slowest and most
expensive, two features that do not recommend it to investigators
looking for prompt returns, or to those with limited funds and
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facilities. With trypanosome infections, or with most bacterial
infections, results are obtained in a few days. A tuberculous infec-
tion in the most suitable animals, guinea pigs and rabbits, may last
for the better part of a year, and the single experiment is not
ordinarily terminated until all of the animals have died.
Ten years ago our ideas of chemotherapy were based mainly on
Ehrlich's original principle of selective affinities between the bacteri-
cidal chemical and the bacterial protoplasm, made effective by a lack
of affinity between this chemical and the protoplasm of the host.
There were plenty of substances that would kill tubercle bacilli in
cultures, and many that even in great dilution would inhibit their
growth. The problem was to find some way of getting these sub-
stances into the tubercle in sufficient concentration to be at least
inhibitory to the growth of the tubercle bacillus without being too
damaging to the more delicate cells of the host. It was recognized
from the start that there were two major obstacles to the accomplish-
ment of this purpose. One was the fact that the tubercle bacillus
was more resistant to injury than most bacteria not so well armored
with wax. The other was that the avascular character of the ordi-
nary tuberculous lesions rendered them less accessible to chemothera-
peutic agents than the normal tissues that we did not want to injure.
To offset these drawbacks there were certain potential assets.. One
was the possibility that the avascular nature of the tubercle might
permit accumulation and retention of the chemotherapeutic agent in
the necrotic center, just as calcium and cholesterol accumulate in
tubercles. The other was the definite benefit that had been obtained
in the treatment of leprosy. If a chemical agent in chaulmoogra oil
could check the attack of the acid-fast leprosy bacillus, it was
perfectly possible that something might do as much to the tubercle
bacillus. With these facts to give encouragement, and Ehrlich's
principles to lead the way, we started out on the laborious task of
seeking a specific chemotherapeutic agent that might prove to be at
least as valuable as is chaulmoogra oil in leprosy, if not as specific as
is salvarsan in syphilis.
The facts that had been accumulated in 1922 and duly presented
in The Chemistry of Tuberculosis may be briefly summarized as
follows: No substance had yet been found that exerted any definite
chemotherapeutic effect in tuberculous animals. Most of the com-
pounds tried generally shortened the life or decreased the resistance
of the animals tested, although a few seemed to be somewhat bene-
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ficial to the extent of lengthening the average life of a series of
tuberculous animals or decreasing the dissemination of the disease in
infected animals. Nothing had been found that would cure tuber-
culous infection in guinea pigs or rabbits. However, it was recog-
nized that this was possibly an unreasonably severe requirement, in
view of the low resistance of these animals, especially when com-
pared with tuberculosis in human adults, which is generally a rein-
fection or relighting of infection in a partially immune host. No
one had then, or has yet, devised a satisfactory experimental test
animal to correspond closely in resistance to the human consumptive;
man alone has classical phthisis pulmonalis.
The Permeability of Tubercles
Certain definite things had been established of more or less value
as a working basis for chemotherapeutic study. The possibility of
getting chemical agents into tubercles had been studied. Loeb and
Michaud* had shown that iodides entered tubercles readily. Wells
and Hedenburg confirmed this, but found that it was not a special
case. They demonstrated that any necrotic tissue, equally whether
tuberculous caseation or anemic necrosis, as well as the fluids of sup-
puration and exudation, is readily permeable to any crystalloid dis-
solved in the blood, so that there tends to be an equilibrium between
the crystalloids of the blood and the necrotic tissue or exudate. The
soluble salts studied by them entered and left the tubercles equally
readily, not tending to accumulate or to reach a higher concentration
than in the blood. Such a large colloidal molecule as egg albumin
would not diffuse into the tubercles, but DeWitt, Lewis, and others
found that not only crystalloidal dyes but also dyes of small colloidal
dimensions might enter tubercles. Corper found that dyes selec-
tively accumulating in fats (Sudan III, Scarlet R) did not enter the
fats in tubercles in living animals nor into the fatty substance of the
tubercle bacilli, although these dyes saturated the fat in the adipose
tissues. He also demonstrated, what seems to be a matter of much
importance in chemotherapy, that soluble salts of metals (he studied
chiefly copper salts) when injected into animals tend to go into a
colloidal state, either as metals or protein compounds, and to behave
like the same metals injected as colloids-hence they do not readily
enter caseous tubercles.
* For bibliography, where not cited in this article, see The Chemistry of Tuber-
culosis: Wells, DeWitt and Long, 1923 and 1932, Williams and Wilkins.
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The failure of fat-soluble stains to enter tubercles and tubercle
bacilli in tubercles was ablow to the logical hope that the fatty nature
of the tubercle bacillus might furnish a vulnerable spot in its armor.
This was accentuated by the observation by Hope Sherman that fat
stains do not readily stain tubercle bacilli, while such dyes as basic
fuchsin, eosin, and methylene blue, which are not fat dyes, stain them
readily. Also DeWitt and Sherman found that, contrary to expec-
tation, fat-soluble antiseptics are relatively ineffective on tubercle
bacilli, and fat-insoluble antiseptics are effective.
ChJiemotherapeutic Dye Compounds
Many dyes and other substances, especially if in colloidal state,
are picked up by macrophages, and as the periphery of tubercles con-
tain many suchi phagocytic cells these substances accumulate about
the tubercles, but not inside where most of the tubercle bacilli are.
When Lewis demonstrated that trypan red penetrates to the caseous
center of fully formed tubercles, and DeWitt found that trypan blue
and methylene blue also penetrated the caseous material, the possi-
bility of getting dyes in contact with tubercle bacilli was established.*
Lewis found that azo and eurhodine dyes as a group inhibit the
growth of tubercle bacilli in cultures somewhat specifically. But
trypan red and trypan blue, although both are azo dyes and able to
penetrate tubercies, did not cure tuberculous guinea pigs or stop the
progress of the infection even when the animals were saturated with
the dyes. Since these dyes penetrate the tubercies so well, DeWitt
tried to use them as vehicles to carry inhibitory agents to the bacilli.
Many compounds of the dyes were made with silver, copper, iron,
and mercury, but none of them cured tuberculous guinea pigs; only
the mercury salt seemed to decrease somewhat the rapidity and
extent of the infection. Lewis was equally unsuccessful with com-
pounds of Niagara blue, trypan blue, and trypan red, combined wit71
iodine, phenol, and other substances, using tuberculosis of the rabbit's
eye as the test infection. Also several diazo creosote dyes werc
made, none being curative, but some of which slightly prolonged
life. As methylene blue is a dye that penetrates tubercles readily
* It is intcresting to find a German investigator in 1929 exulting over his
demonstration that a dye will enter caseous tubcrcles (Beitr. z. Klin. Tuberk., 1929,
72, 184) and a reviewer mentioning this as one of the important discoveries of
the year.
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DeWitt made many compounds with this dye as a vehicle to intro-
duce antiseptics into tubercles, some of which seemed to decrease the
extent of tuberculosis in the guinea pig, although not curative. She
could not corroborate von Linden's claims for the great therapeutic
value of methylene blue iodide. We also had prepared for her
testing many compounds of mercury with dyes and tried their effects
in great numbers of tuberculous guinea pigs. In some sets of
experiments certain mercurialized dyes (especially mercury trypan
blue, methylene blue and methylene green mercuric chloride),
seemed to reduce definitely the spread and rapidity of the tubercu-
lous infection. But it was not always possible to secure this same
apparently beneficial result when the experiment was repeated a year
later with a different lot of animals and a different strain of tubercle
bacilli.
Guaiacol and Creosote
These drugs had once had a great vogue in the treatment of
pulmonary tuberculosis, and the drug factories put out for use in
tuberculosis a vast number of compounds with a guaiacol or creosote
nucleus. However, our experiments had shown that creosote and
guaiacol are not strongly bactericidal for the tubercle bacillus, and
that it requires a concentration of 1: 2000 creosote or guaiacol even
to inhibit growth in cultures, 1:1000 being unable to kill in 24 hours'
exposure. Chemotherapeutic experiments in guinea pigs with creo-
sote, guaiacol, creosol, thiocol, styracol, orthocresol, metacresol,
paracresol, and thymol all failed to show any recognizable good
effect on the course of the tuberculosis, and the following decade has
added no more evidence of chemotherapeutic value in this series of
compounds.
Chaulmoogrates and Morrhuates
Naturally the success in the treatment of leprosy with chaul-
moogra oil and its constituents aroused hope that these substances
might also give help in tuberculosis, especially as Walker and
Sweeney had found that chaulmoogra oil contains substances about
I 00 times as bactericidal as phenol, and specific for acid-fast bacilli.
However, Walker found no evidence that the chaulmoogric acid
entered tuberculous lesions, and his experimental therapeutic results
were largely negative. Culpepper and Ableson tested the ethyl
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esters of four acids obtained from chaulmoogra oil on tuberculous
guinea pigs, and reported marked beneficial effects. Despite this,
however, the more recent literature fails to show any striking effect
in either experimental or clinical tuberculosis from the use of the
chaulmoogrates. Similar lack of observable benefit has been the out-
come of the attempts to treat tuberculosis with the sodium salt of
morrhuic acid from cod-liver oil, which Rogers thought would dis-
solve the fattysheath of tubercle bacilli. The same has been the fate
of numerous other drugs that were advocated as solvents of tubercle
bacillus waxes, such as choline and compounds thereof, taurine,
xylene, and terpenes of various sorts.
Arsenicals
Ehrlich's success with arsenicals naturally incited interest and
hope in organic compounds with metals. Arsenic had long been used
in tuberculosis, mainly for its effect on general nutrition and tissue
metabolism, for arsenic has been called "the digitalis of metabolism".
The possibility of specific arsenical treatment of tuberculosis was
made remote when Arkin and Corper tested sodium arsenite, sodium
cacodylate, atoxyl, arsacetin, and neosalvarsan for tuberculocidal
power, and found none. They found that arsenic did not accumu-
late in the tuberculous tissues of experimental animals. M. I. Smith
likewise found but little inhibiting effect on tubercle bacilli in vitro,
and no effect on guinea pig tuberculosis, from neoarsphenamine and
silver arsphenamine. Since that time there seems to have been little
attention paid to the possible use ofarsenicals in the chemotherapy of
tuberculosis. But it is to be mentioned that many syphilitics have
been treated and cured with arsenicals without being cured of a
coexisting tuberculosis.
Copper Therapy
In 1922 there was great interest in copper, which had been used
for many decades previously without showing any convincing evi-
dence of value. The interest had been stirred up by a series of
papers, beginning in 1912, by Grafin von Linden and some German
clinicians whom she had apparently fired with her own enthusiasm.
She used particularly a compound of copper with lecithin, promptly
marketed with a trade name in true German style, and claimed that
copper was a specific bactericide for tubercle bacilli, and that copper
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treatment cured tuberculosis in man and beast. Some very good
press notices were obtained for a Japanese copper specific for tuber-
culosis, cyanocuprol (Koga), with a composition that sounds
unwholesome, i.e., two parts of potassium cyanide and one part of
copper cyanurate.
But DeWitt and Sherman found that it took a 5 per cent concen-
tration of copper chloride to kill tubercle bacilli in 24 hours'
exposure. Even 25 per cent CuCI2 did not kill all the tubercle
bacilli in clumps immersed in the solution for 24 hours! Corper
found that copper did not heal tuberculous rabbits and guinea pigs.
He also found that copper did not enter the tubercles, for no matter
in what form it was injected it promptly became colloidal copper,
which was taken up by phagocytes and did not diffuse into caseous
tubercles.
The interest that had been stirred up by the extensive advertising
of von Linden's and Koga's preparations died out almost as fast as
it arose, and since 1923 little has appeared in the literature about
copper and tuberculosis, and nothing that arouses new interest. This
sudden neglect is convincing evidence as to the lack of real value in
copper therapy.
Mercurials
From time to time in old medical history the use of mercury
compounds in tuberculosis has been advocated, but not long pursued.
It is to be considered that the old physicians, who mercurialized their
patients so devoutly-
"The doctor comes with right good will
But ne'er forgets his calomel"-
did not seem to note that mercury cured their many consumptive
clients with any striking regularity.
Very little had been done in trying to utilize mercurial com-
pounds as true chemotherapeutic agents. In 1889 Cornet tried to
cure tuberculous guinea pigs with that popular antiseptic, bichloride
of mercury, this being one of the earliest chemotherapeutic attempts
in the treatment of tuberculosis on the basis of known bacteriological
action. Koch also found that mercury itself would not cure tuber-
culous guinea pigs. But DeWitt found that among many compounds
of dyes with heavy metals that she had prepared for therapeutic
testing, the most definite effects were produced by the mercury dye
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compounds. She found that mercury trypan blue had a high
bactericidal action on tubercle bacilli, and it seemed to have more
effect in reducing the spread of lesions and prolonging the lives of
tuberculous animals than anything else that she tested. Methylene
blue mercuric chloride, methylene green mercuric chloride, and a
few other mercurial compounds of dyes and mercuriated phenols and
anilines, were found to have distinctly beneficial but not curative
effects. With less extensive controls DeWitt might have been
misled into making a less conservative statement than the one in
which she summed up her results: "No mercurials have cured tuber-
culosis in any guinea pig, but some of the results have seemed more
favorable than have resulted from any other metal or from any other
compound so far investigated in this laboratory. This seems to make
the hope possible that some compound of mercury may yet be
developed which may combine low toxicity with high bactericidal or
bacteriostatic power and with lower organotropism and thus have
high chemotherapeutic power in tuberculosis."
This line of work has not been continued since Dr. DeWitt's
death, but her observations contain suggestions for further study.
Paul Lewis also abandoned tuberculosis work in 1923, leaving the
Phipps Institute to work on other problems in the Rockefeller Insti-
tute until the time of his lamented death from yellow fever. Since
that time there has been no further systematic investigation of the
possibilities of developing specific chemotherapeutic dye compounds
with tuberculocidal properties.
Gold in Chemotherapy
Gold has been used in the treatment of tuberculosis (and almost
everything else) since most ancient times, I suppose largely because
of its precious character and royal standing. As a chemotherapeutic
possibility it dates back to 1890 when Robert Koch found it to be a
most potent agent against tubercle bacilli in cultures, gold cyanide
inhibiting growth in dilutions of 1 to 2,000,000. But he found that
it would not cure tuberculous animals. Shortly after this J. B. White
thought that he did get some benefit in animals and in patients by
using the double chloride of gold and sodium, combined with iodide
of manganese, and after this numerous gold salts were recommended
for consumption without any convincing proof of efficiency. The
first extended study of the chemotherapeutic possibilities of gold was
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made between 1912 and 1916 by Spiess and Feldt. These authors
considered gold cyanide and gold potassium cyanide too toxic for use
in human patients. As cantharidin had earlier been found to have
a marked affinity for tuberculous tissues, they conceived the idea of
reducing the toxicity of the cantharidin and using it as a carrier for
the specific gold cyanide. They were able to reduce the toxicity of
the cantharidin 700 times without altering its affinity for tubercles
by condensing it with ethylenediamine. This compound was quite
nontoxic and combined readily with gold cyanide. They used first
the auric salts but found them 100 to 1000 times less efficacious
than the aurous salt, and therefore in their later work they used
mono-cantharidyl-ethylenediamine-aurous-cyanide under the name
"Aurocantan". Although they believed that they had demonstrated
distinct chemotherapeutic effects in experimental animals, they found
the clinical use of the gold cantharidin compound not very satis-
factory. So Feldt has continued to try out various gold compounds,
seeking one that might be less toxic without loss of the distinct
tuberculocidal power of the gold ion.
DeWitt, Cadwell and Leavell investigated the therapeutic value
of various gold salts in experimental tuberculosis in guinea pigs.
The treatment was given by feeding, by subcutaneous injections and
by intracardiac injections. They also determined the distribution of
the gold in the normal and tuberculous tissues by analysis of the
tissues.
DeWitt and Sherman had found that 1 part in 1000 of gold
chloride is required to kill the tuberde bacilli, while I per cent
solutions of gold tricyanide were not always able to kill all the
organisms. However, they found, as did Koch, that the gold
cyanide completely inhibited growth of the tubercle bacillus in the
test-tube in a dilution of 1 in 2,000,000. Feldt states that in vitro
these organisms develop a tolerance to the gold salts, while Shiga
reported that tubercle bacilli developed no tolerance to gold salts.
In DeWitt and Sherman's experiments, tolerance developed so
slowly as not to be an important factor in the treatment of the disease
in guinea pigs. Both the simple gold cyanides and the canthari-
dylethylenediamine aurous cyanide recommended by Spiess and
Feldt were used and no, or very little, effect was seen on the disease,
except that life in general was shorter and the disease more
pronounced in the treated animals than in the controls.
The amounts of gold found by analysis in the liver, spleen and
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lungs and other sites favored by tubercles in the animals treated by
DeWitt are many times the concentration necessary in the test-tube
to inhibit growth completely. The fact that tubercle bacilli grow
luxuriantly in organs containing such an amount of gold is appar-
ently explained by microchemical studies of the tissues of tuber-
culous animals and men treated with gold salts, which show that the
gold is not in the tubercles where it might act upon the bacilli, but
outside the tubercles in the reticulo-endothelial cells.
As most of the facts mentioned in the preceding paragraphs were
known in or before 1923 the excitement aroused in some quarters in
1924 by M0llgaard's claims for "sanocrysin" seems to reflect on
either the information or the judgment of the enthusiasts. The
careful, detailed studies of Feldt, and of DeWitt and her co-workers,
had given a sound basis of knowledge concerning the behavior and
effects of gold compounds in the normal and in the tuberculous
animal. As sanocrysin is merely an inorganic salt of gold, a double
thiosulfate of gold and sodium, with the gold in trivalent form,
(S2O3Au) Na2O, those familiar with the previous work on gold
compounds could anticipate no properties not exhibited by the other
gold salts already studied. It was already recognized that gold, in
common with other metallic poisons, when introduced into the tuber-
culous animal leads to acute intoxication, associated with hyperemia,
hemorrhage and edema about the tuberculous lesions, much
resembling the reaction to tuberculin. It was appreciated that this
effect might, under certain conditions, have possible therapeutic
value whether induced by chemicals or tuberculin. There was no
good evidence that gold has anything resembling a specific chemo-
therapeutic effect on the tubercle bacilli. Ehrlich's demand for
"magic bullets" to destroy the invaders was not met even by gold
missiles. Therefore any therapeutic value in gold salts must lie in
the tuberculin-like effect, and there was much reason to doubt
that a mineral poison would prove as safe an agent as tuberculin
itself. The situation was well summarized by DeWitt in her con-
cluding statement: "From all the experiments, we may conclude
that the use of gold salts is not without danger. When active, their
action seems associated with marked hyperemia and possible hemor-
rhages in the neighborhood of the tubercles. This tuberculin-like
reaction might, if uniform and if it could be regulated and relied
upon, produce certain beneficial connective tissue changes in the
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neighborhood of the tubercle, but the regulation seems too difficult
and dangerous to make gold therapy ever a treatment of choice."
There is little justification for M0llgaard's idea that the toxic
effects seen in tuberculous men and animals given sanocrysin, result
from tuberculin liberated from tubercle bacilli killed by the drug.
It has been observed that gold treatment often produces a lighting
up of old tuberculin skin reactions, but it is not known whether this
depends upon the setting free of tuberculin, or on hyperemia in the
sensitized capillaries from the toxic action of the gold, or is a non-
specific allergic reaction either to disintegration products of the
tubercle or to gold protein compounds. The belief that a specific
antitoxic serum could be prepared to counteract tubercle bacillus
endotoxins was contrary to immunological principles, and has not
been supported by subsequent experience. More probably the toxic
effects observed in sanocrysin treatment, to the extent that they are
produced more in tuberculous than in normal animals, result from
disintegration by accelerated autolysis in the tuberculous lesion, and
increased absorption because of the hyperemia. This seems to be
analogous to the effect of mercury and bismuth in hastening autolysis
of syphilitic lesions independent of any action on the spirochete.
The greater toxicity of sanocrysin in tuberculous than in normal
animals is no evidence of a specific tuberculocidal effect. It may
depend, according to Peterson and Levinson, on the presence in
tuberculosis of an increased permeability of the endothelium, which
is increased transiently by small doses, followed by a relative
impermeability. Many other substances, from peptone to copper,
behave like gold in that they produce different effects in tuberculous
and non-tuberculous animals.
There is no evidence that sanocrysin has any particular virtue as
a bactericidal agent; like all gold salts it has a high inhibitory value,
but it has no noticeable bactericidal effect even in concentrations as
great as 1: 2000 for 2 hours. Its inhibitory effect is largely pre-
vented by the presence of blood proteins, e.g., in experiments with
blood clots.
Early claims of a marked capacity to cure tuberculosis in rabbits,
even with sterilization of the lesions, have not been substantiated by
later investigations. Neither has confirmation been furnished the
theory that sanocrysin behaves differently from other gold salts in
the animal body. Hansborg has demonstrated that in sanocrysin
treatment the gold promptly loses its easily diffusible character, and
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behaves like other heavy metals, being held and slowly excreted so
that it may be detected in urine and stools after eight months.
Gallinal found abundant gold microchemically in the tissues of a
person who had last received sanocrysin ten months before death. In
dogs it is excreted in the urine for at least 30 days, producing the
usual toxic effects of metallic poisons, i.e., albuminuria, vomiting,
diarrhea. Possibly somewhat more gold is retained in the tuber-
culous than in normal animals, and histological evidence supports
this view.
Both microscopic and analytical studies have shown that sano-
crysin treatment leads to much the same gold distribution in the
organs of tuberculous or normal animals, produces about the same
toxicological and therapeutic effects, and exhibits no particular dis-
tinction from the numerous other gold compounds that have been
investigated. The gold seems to be taken up chiefly in the reticulo-
endothelial cells. It has been shown that introduction of small
amounts of foreign materials of many sorts into these cells stimu-
lates their immunological activity, and this may explain some of the
effects of metallic and dye therapy in tuberculosis and other diseases.
German investigators and chemical houses are putting out
numerous new gold compounds in the search for one that will have
the minimum toxicity without loss of the tuberculin effect, and they
may be trusted to continue doing so. But as yet there seems to be
no reason to hope that gold compounds will be found to have any
specific chemotherapeutic effect, in view of the fact that the gold
does not enter the tubercles in appreciable amounts. On the other
hand, many clinical studies indicate that gold salts have a certain
therapeutic value, when properly used in selected cases. This value
they seem to owe solely to their tuberculin-like effect on the tuber-
culous lesions, and there is much reason to believe that this effect can
be equally well secured with less danger by proper use of tuberculin.
And certainly, review ofthelarge amount of literature on the clinical
use of sanocrysin and other gold compounds shows that even in the
reports of the enthusiasts the claimed effects are not usually striking.
There are plenty of testimonials to throw doubt on the actual value
of gold therapy, and also numerous objections to its dangers. (See
Amberson, McMahon, and Pinner: Am. Rev. Tuberc., Oct., 1931.)
Sanocrysin does not evade the general hazard of metallic poisons,
producing intestinal, cutaneous and, especially, renal lesions.
Most careful observers will probably agree with the statement of
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Unverszagt: "The improvement in pulmonary tuberculosis after
gold therapy in general is not much better than is to be obtained
merelyby a climatic cure. However, there is often shown a decrease
in the number of bacilli in the sputum. As a stimulation therapy,
not a chemotherapy, in suitable cases, gold therapy is an addition to
our methods of treatment, although it has not fulfilled the great
expectations it has aroused."
In view of the foregoing general considerations and the experi-
mental nature of the work with numerous other new gold com-
pounds, it is not profitable to give extended consideration to all the
reports now available. We may mention the observations of Fischer
that in order of decreasing toxicity are: triphal (sodium auro-thio-
benzimidazole carboxylic acid); sanocrysin (sodium gold thiosul-
fate); solganol (C7HuOuNS3Na2Au); and lopion (auroallylthio-
ureabenzoate of sodium). Feldt has also described some new gold
compounds which are but one-tenth as toxic as krysolgan, with
equally active therapeutic effects in proportion to the gold
administered.
Henius and Weiler studied the distribution of gold in the animal
body after administration of various gold compounds, finding that
lopion accumulated chiefly in the liver, whereas with solganol and
sanocrysin the gold was mostly in the kidneys. With solganol an
especially large proportion of the gold accumulated in the tuber-
culous lung. Apparently the bactericidal and inhibitory effects of
goldsalts depend less upon the anion than upon the strain of tubercle
bacilli tested.;
All gold compounds have more or less toxiceffects onthekidneys
and intestines, apparently because of excretion by these organs.
Fischer found sanocrysin particularly toxic to the kidneys, while
solganol injured the kidneys least but was toxic to the intestines.
HeniusandWissingcorroboratedthelowtoxicityoflopion,especially
in respect to the kidneys. They observed clinical benefit, but state
that it is "Nicht ein besonders wunderwirkendes Heilmittel."
Schamberg, Harkins, and Brown, impressed by the fact that of 22
salts of metals and metalloids brought in contact with tubercle
bacilli, the gold ion had the highest combining power, have tested
several new gold compounds prepared in their laboratory. No effects
could be produced in guinea pigs infected subcutaneously, but intra-
dermal infections in rabbits seemed to be somewhat repressed by
treatment with gold compounds.
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Metal Treatment a la Walbum
Another possibility in therapeutics of tuberculosis has been
opened by Walbum, who observed that several sorts of metallic
elements, given in the form of salts in extremely small doses,
greatly modify the immunological response of animals to antigens
and infections. With his colleagues he has found that the pro-
duction of antitoxin, amboceptors, and bactericidal antibodies could
be enhanced by injecting optimal minute amounts of salts of several
different metals, especially caesium, manganese and iridium. Man-
ganese chloride was found to protect tuberculous guinea pigs from
tuberculin shock. Large doses of the metals decrease immunological
activity, and there is a great difference in effect with small changes
from the optimal concentration, too large doses seeming to stimulate
the parasite rather than the defensivle mechanism.
He suggests that perhaps the parasite, protected by its denser
outer layers, is unaffected by the small amounts of metal that stimu-
late the highly differentiated naked cells of the host. This, perhaps,
is why there seems to be such a marked discrepancy between the
effects in vitro and in vivo, and why the large doses of gold salts
used at first were found less useful than smaller doses.
Walbum tested 42 different metals in the treatment of rabbits
with tuberculosis that had existed 33 days before beginning the treat-
ment, and found only two, cadmium and manganese, that exhibited
a pronounced curative effect. Eight others (cerium, barium, alu-
n,inum, lanthanum, molybdenum, platinum, nickel, and samarium)
were said to show a slight effect. The doses used in guinea pigs are
extremely minute, e.g., from 0.05 to 3 cc. of a 0.0001 mol. solution,
the proper amount being determined by the production of a febrile
reaction. Larger than optimum doses are likely to be detrimental.
Much less marked results were obtained in guinea pig experiments
than with rabbits, but human experiments have been conducted with
these undoubtedly harmless quantities of metal salts.
In 1929 Lunde reported on 600 clinical cases treated by Wal-
bum's method during four years, using cadmium, manganese, sano-
crysin, beryllium, and aluminum. It is said that the sputum
becomes free of tubercle bacilli more frequently, and the recovery is
more rapid than was observed before this treatment was instituted.
Best results were obtained by using both cadmium and manganese,
with beryllium in cases with mixed infection. On the other hand,
Larsend and Torning in a small series observed no better results
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than are generally obtained during sanitarium residence. Frederik-
sen, however, obtained with manganese injections (0.03 molar)
improvement which he likens to that obtained with sanocrysin.
There seems to have been no general adoption of this method as a
panacea, or even as aremarkably promising advance in the therapy of
tuberculosis.
General Considerations
Since 1922 we have come to recognize more and more that
chemotherapy in the sense in which Ehrlich introduced the term, is
more of a dream than a reality. Even his apparent demonstration
of the principle with salvarsan turned out to be something quite
different from what he had supposed, for it was soon found that
salvarsan is not a specific germicide acting on the spirochetes selec-
tively; in fact, it is not very toxic to spirochetes. Apparently it is
the disintegration of the salvarsan in the tissues which leads to the
production of a partially oxidized derivative which is highly toxic
for the parasites. And so we have had to take into consideration
other factors, especially the tissue factors, more than we did at first.
Particularly, the role of the reticulo-endothelial system has come
more into the foreground in chemotherapy, as it has in immunology.
In tuberculosis the reticulo-endothelial cells seem to play more than
one defensive role. As phagocytes they are of chief importance,
most of the tubercle bacilli, after a brief sojourn in the polymorpho-
nuclear leukocytes, being found inside reticulo-endothelial cells.
Next, they are the chief cells that form the encapsulating tissue to
limit the spread of the infection; and also, it is to be presumed,
they act as prime factors in the immunological defense against the
tuberde bacilli as they seem to act against other pathogenic bacteria.
In addition to this they seem to play a formerly unsuspected role in
chemotherapy, for it has been found that if the amount of available
reticulo-endothelium is reduced by splenectomy or by blockade, the
efficiency of chemotherapeutic agents is correspondingly reduced.
(For the literature on this subject, see: Jungeblut and McGinn:
J. Exper. Med., 1930, 51, 5.) This may possibly be because the
chemotherapeutic agent acts mainly by stimulating the reticulo-
endothelial cells, or because these cells transform the drug into a
more potent form. It is to be noted that most of the chemothera-
peutic agents that have seemed to accomplish some increased resis-
tance to tuberculosis, have been substances that are taken up by the
reticulo-endothelium. Experiments have shown that introducing
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moderate amounts of foreign substances into the reticulo-endothelial
cells stimulates their activity, only nearly complete saturation
reducing their function. Hence it is possible that metal therapy and
dye therapy are merely methods for stimulating this defensive
mechanism, and not at all a parasiticidal chemotherapy.
Although the last decade has seen an almost complete abandon-
ment of systematic experimental research on the specific chemo-
therapy of tuberculosis, this fact by no means proves that there
remains no possible future for this principle. But it certainly seems
reasonable to believe that tuberculosis offers less prospect of early
success than almost any other bacterial infection, considering the
resistance of the tubercle bacilli and the highly protective wall of
active and labile macrophages separating them from the chemothera-
peutic agent. We can hardly expect a triumph here before the
chemotherapeutic conquest of less resistant organisms in a less pro-
tected environment, as with typhoid, erysipelas, bacterial endocar-
ditis, to name a few typical examples.
We may take some hope from the suggestion of Hilgermann
(Muinchen. med. Wchnschr., 1930, 77, 1477) that a chemothera-
peutic agent that only kills, or renders vulnerable, a few of the
infecting bacteria, may turn the scale by virtue of the immunological
reactions incited by the destroyed bacteria at the point where the
infection exists, for we are learning more and more that local defen-
sive mechanisms are particularly potent (Gay, Cannon). Our fears
that the binding effect of blood proteins on our chemotherapeutic
agents is too effective to permit them to function are also somewhat
allayed by the observation of Wright and Hirschfelder (J. Pharm.
& Exper. Ther., 1930, 38, 433) that dyes adsorbed on proteins still
exhibit antiseptic action; and of the Stearns (J. Exper. Med., 1930,
51, 341), who found that dyes can act on bacteria even when the
blood proteins seem to be in excess, and that apparent disappearance
of a dye from the blood does not mean that all bacteriostatic value
is lost.
A specific chemotherapy of tuberculosis has not been found, and
it may be a long time in coming because of the inherent difficulties of
the problem, but it is not a closed chapter. We have some definite
facts to go on, and some glimpses of light have been seen. Probably
some new success with some other bacterial infection will be needed
to stimulate a new attack on the more difficult problem offered by
tuberculosis.
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